Product Description
Cdk4 Inhibitor is an indolocarbazole which is a potent, selective and ATP competitive cyclin D1/CDK4 inhibitor. It has an IC₅₀ value of 76 nM. It inhibits tumor cell growth, arrests tumor cells at the G1 phase, and inhibits pRb phosphorylation in HCT-116 and NCI-H460 cells with IC₅₀ < 3.0 µM.
Cdk4 Inhibitor is an indolocarbazole which is a potent, selective and ATP competitive cyclin D1/CDK4 inhibitor. It has an IC₅₀ value of 76 nM. It inhibits tumor cell growth, arrests tumor cells at the G1 phase, and inhibits pRb phosphorylation in HCT-116 and NCI-H460 cells with IC₅₀ < 3.0 µM.
Biovision | B2928 | Cdk4 Inhibitor DataSheet
Alternate Name/Synonyms: 2-Bromo-12,13-dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione; K00024; Cyclin-dependent kinase 4 Inhibitor
Appearance: Solid
Formulation:
CAS Number: 546102-60-7
Structure Available?: True
Peptide sequence:
Salt Form: false
Molecular Formula: C₂₀H₁₀BrN₃O₂
Molecular Weight: 404.22
Cell-Permeable?: True
Purity: 95%
Solubilities: ~30 mg/ml in DMSO and DMF in 0, ~0.25 mg/ml in in Ethanol
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: A potent cyclin D1-CDK4 inhibitor
MDL Number:
PubChem CID: 5330797
SMILES: C1=CC=C2C(=C1)C3=C4C(=C5C6=C(C=C(C=C6)Br)NC5=C3N2)C(=O)NC4=O
InChi: InChI=1S/C20H10BrN3O2/c21-8-5-6-10-12(7-8)23-18-14(10)16-15(19(25)24-20(16)26)13-9-3-1-2-4-11(9)22-17(13)18/h1-7,22-23H,(H,24,25,26)
InChi Key: NMFKDDRQSNVETB-UHFFFAOYSA-N